Skip to main content
. 2019 Oct 9;8(10):466. doi: 10.3390/antiox8100466

Table 1.

Kidney physiological parameters (value ± S.D.).

Parameters Week 0 Week 2 Week 4 Week 6
Body weight (g) G1 Control 36.26 ± 1.41 35.26 ± 1.47 35.34 ± 1.47 33.10 ± 0.93
G2 nHNK 34.15 ± 1.35 35.03 ± 1.35 33.35 ± 1.45 32.71 ± 1.29
G3 Cisplatin 37.74 ± 0.93 35.46 ± 1.14 32.35 ± 1.45 29.18 ± 1.46*
G4 Cis/nHNK 37.39 ± 1.71 35.28 ± 1.24 34.43 ± 0.84 33.55 ± 1.08
Urine Osmolarity (mOsmol)/kg G1 Control 3100.0 ± 50 2516.7 ± 36 3140.0 ± 407 2856.3 ± 25
G2 nHNK 3050.0 ± 351 2425.0 ± 70 2891.7 ± 436 3390 ± 590
G3 Cisplatin 3088.2 ± 456 1735.9 ± 78 1168.1 ± 83 1558.3 ± 183
G4 Cis/nHNK 2489.4 ± 347 1815.5 ± 198 1087.5 ± 75 1587.5 ± 188
Serum BUN (mg/dl) G1 Control 20.84 ± 2.49 25.20 ± 2.35 21.6 ± 1.63 20.40 ± 1.91
G2 nHNK 22.25 ± 3.10 24.25 ± 3.30 23.50 ± 3.90 18.25 ± 1.25
G3 Cisplatin 20.81 ± 1.79 20.00 ± 2.12 27.33 ± 3.18 47.00 ± 13.8*
G4 Cis/nHNK 21.50 ± 4.00 20.75 ± 1.25 22.50 ± 4.17 18.00 ± 4.17
Serum creatinine (mg/dl) G1 Control 0.160 ± 0.02 0.130 ± 0.03 0.130 ± 0.03 0.140 ± 0.04
G2 nHNK 0.130 ± 0.03 0.130 ± 0.03 0.100 ± 0.00 0.130 ± 0.03
G3 Cisplatin 0.100 ± 0.00 0.130 ± 0.02 0.170 ± 0.02 0.230 ± 0.05*
G4 Cis/nHNK 0.100 ± 0.00 0.143 ± 0.02 0.167 ± 0.03 0.100 ± 0.00
Serum indoxyl sulfate (ppm) G1 Control 2.017 ± 0.27 3.043 ± 0.55 1.988 ± 0.35 2.600 ± 0.58
G2 nHNK 2.302 ± 0.33 2.911 ± 0.61 1.810 ± 0.32 1.584 ± 0.23
G3 Cisplatin 2.021 ± 0.56 5.074 ± 2.08 7.694 ± 0.95* 8.591 ± 0.51*
G4 Cis/nHNK 2.397 ± 0.51 4.491 ± 1.64 5.256 ± 0.85 5.058 ± 0.95

1. Ctrl.: vehicle control (100 μL corn oil); nHNK: 5 mg/kg liposome-encapsulated honokiol alone, IP; Cisplatin: 10mg/kg cisplatin alone, IP; Cis/nHNK: 10 mg/kg cisplatin + 5 mg/kg Honokiol. 2. * indicates the G3 cisplatin group is significantly different (p < 0.05) from the G4 (treatment) cisplatin + honokiol group.